Ontogen botanicals CBD is able to help you track your CBD therapy results. After creating a login on the website and purchasing product(s), you will see a button to complete condition specific surveys to assess how you respond to Ontogen CBD therapy over time. Each time you make a purchase, using a very secure server, outcomes data that will be presented to inform your future product choices. Also, most news outlets that lean toward an obvious negative cannabinoid medicine viewpoint end with the caveat that there’s no research available. There is research to be found, see the ontogen.life/research tab. YOU, only with your okay, can also help by contributing anonymous (de-identified) outcomes data for research. There will be zero connection to you personally as your results will be stripped of personal info. If you are a researcher, contact us if you are looking for such anonymous data.

Labeling Accuracy of Cannabidiol Extracts Sold Online

This article is from before passage of the 2018 Farm Bill, which legalized industrial hemp by removing the crop from the Controlled Substance Act’s definition of “marijuana,” will lead to increased sales and growing opportunities for hemp-derived cannabidiol (“Hemp-CBD”) companies in 2019.

Cannabidiol (CBD) — what we know and what we don’t


NY Times article that gives an explanation of the possible benefits of CBD:

Velasquez-manoff, M. (2019, May 15). Can CBD Really Do All That? Retrieved from | https://www.nytimes.com/interactive/2019/05/14/magazine/cbd-cannabis-cure.html

Simple Summary of Mitch McConnell’s Federal U.S. 2018 Farm Bill that was signed into law by the President:

Forbes Magazine Simple Summary of 2018 Federal Farm Bill

Overarching Article with ~100 Research References from Peer-Reviewed Journals:

You can read interesting cited insights on disease states, and then go to cited research for more in-depth discoveries:

Russo, Ethan B. “Taming THC: Potential Cannabis Synergy and Phytocannabinoid-Terpenoid Entourage Effects.” British Journal of Pharmacology, vol. 163, no. 7, 2011, pp. 1344–1364., doi:10.1111/j.1476-5381.2011.01238.x.

World Health Organization Report on Cannabidiol


Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly

Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic paid in a medical cannabis cohort

Specific Research References from Peer-Reviewed Journals:

Marchalant Y, Brothers HM, Wenk GL. Inflammation and aging: Can endocannabinoids help? Biomedicine & Pharmacotherapy. 2008;62(4):212-217. doi:10.1016/j.biopha.2008.02.004.

Panikashvili D, Simeonidou C, Ben-Shabat S, et al. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature. 2001;413(6855):527-531. doi:10.1038/35097089.

Hampson AJ, Grimaldi M, Axelrod J, Wink D. Cannabidiol and (-) 9-tetrahydrocannabinol are neuroprotective antioxidants. Proceedings of the National Academy of Sciences. 1998;95(14):8268-8273. doi:10.1073/pnas.95.14.8268.

Jiang W. Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. Journal of Clinical Investigation. 2005;115(11):3104-3116. doi:10.1172/jci25509.

Mckallip RJ. Cannabidiol-Induced Apoptosis in Human Leukemia Cells: A Novel Role of Cannabidiol in the Regulation of p22phox and Nox4 Expression. Molecular Pharmacology. 2006;70(3):897-908. doi:10.1124/mol.106.023937.

Mechoulam R, Parker LA, Gallily R. Cannabidiol: An Overview of Some Pharmacological Aspects. The Journal of Clinical Pharmacology. 2002;42(S1). doi:10.1002/j.1552-4604.2002.tb05998.x.

Cannabidiol and (-)?9-tetrahydrocannabinol are neuroprotective antioxidants | PNAS


Not peeer-reviewed but informative – How CBD Works


A Personal Retrospective: Elevating Anandamide (AEA) by Targeting Fatty Acid Amide Hydrolase (FAAH) and the Fatty Acid Binding Proteins (FABPs)

From Stony Brook Univ world-renowned cannabinoid researcher Dr. Dale Deutsch – https://www.frontiersin.org/articles/10.3389/fphar.2016.00370/full